Venclax is Venetoclax (Micronized), an oral BCL-2 inhibitor. It is indicated for CLL, small lymphocytic lymphoma, and selected AML regimens and works by restoring apoptotic signaling in BCL-2 dependent malignant cells.
| Product Name | Venclax |
| Generic Name | Venetoclax(Micronized)+Dibasic Calcium Phosphate (Anhydrous calcium Hydrogen Phosphate) |
| Formulation | Tablet |
| Available Pack Size | 3X10's, 5X6's |
| Available Strength | 10 mg, 100 mg |